Summary Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Sz?ntay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis Market Segment as follows: By Type Tablet Injection By Application Household Hospital By Company Runhong Gedeon Richter Sun Pharma WZT PUDE Welman ZhiTong Liaoning Zhiying COVEX Northeast Pharma Micro Labs The main contents of the report including: Section 1: Product definition, type and application, global and China market overview; Section 2: Global and China Market competition by company; Section 3: Global and China sales revenue, volume and price by type; Section 4: Global and China sales revenue, volume and price by application; Section 5: China export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion.
Table of Contents 1 Market Overview 1.1 Market Segment Overview 1.1.1 Product Definition 1.1.2 Market by Type 1.1.2.1 Tablet 1.1.2.2 Injection 1.1.3 Market by Application 1.1.3.1 Household 1.1.3.2 Hospital 1.2 Global and Regional Market Size 1.2.1 Global Overview 1.2.2 China Overview 2 Global and Region